Nirmal S Aujla, MD
Nephrology · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
- Since medical school
- 46 years
- Graduated 1980
Offices
3 locations · Merced Turlock Nephrology Med Group Inc. · 2 clinicians in this group
Looking this up.
Hospitals listed: 552647 · Emanuel Medical Center · Mercy Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aujla’s office at (209) 723-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A42706 · Current
Licensed to practise in California · since 1986 · expires 2028-04-30 · Punjab University, Government Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emanuel Medical CenterTurlock, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.231, Oct 2024 – Sep 2025
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
See every measure and the patient survey for Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 622 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.82 (131.99 to 239.65) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 443 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,680 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,151 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.2 to 5.87) · 700 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.43) · 734 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,326 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.908 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.836 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.997 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 307 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.8 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.8 · 417 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.9 · 472 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 524 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.6) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.4 to 12.8) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.3) · 257 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 289 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 14% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$74,148
Medicare paid this office $74,148 for 168 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $37,286 | $254 |
| Return visit (30+ min) | 62 | $13,527 | $82 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $6,108 | $211 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $4,917 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $2,949 | $84 |
See all 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $37,286 | $254 |
| Return visit (30+ min) | 62 | $13,527 | $82 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $6,108 | $211 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $4,917 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $2,949 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $2,465 | $123 |
| Short return visit (20+ min) | 21 | $1,913 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 45 | $711 | $12 |
Who their Medicare patients are
168 Original Medicare patients in 2024. Average age 74 · Under 65 18% · 85 and older 16% · Women 48% · Also on Medicaid 61% · Health risk score 4.22. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 73% · Heart failure 49% · Coronary heart disease 43% · Atrial fibrillation 35% · COPD 29% · Depression 21% · Stroke 21% · Dementia 14% · Cancer 13%.
The office billed $169,280, Medicare allowed $98,538 and paid $74,148; for 617 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 168 | 617 | 74 | 4.22 | $169,280 | $74,148 |
| 2023 | 191 | 747 | 75 | 3.92 | $190,375 | $108,200 |
| 2022 | 232 | 950 | 75 | 4.01 | $265,850 | $164,779 |
| 2021 | 225 | 1,009 | 73 | 3.87 | $291,910 | $180,753 |
| 2020 | 294 | 1,377 | 74 | 4.06 | $353,010 | $177,683 |
| 2019 | 464 | 2,415 | 73 | 3.89 | $529,260 | $275,507 |
| 2018 | 494 | 2,658 | 73 | 3.77 | $591,380 | $310,955 |
| 2017 | 506 | 2,528 | 73 | 3.93 | $578,290 | $295,620 |
| 2016 | 548 | 3,520 | 72 | 4.10 | $736,600 | $378,720 |
| 2015 | 572 | 3,378 | 72 | 3.66 | $638,870 | $380,670 |
| 2014 | 568 | 3,683 | 72 | 3.65 | $687,050 | $416,183 |
| 2013 | 708 | 4,251 | 72 | 3.50 | $682,270 | $407,831 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 28 | $57,205 | $282 |
| Return visit (30+ min) | 68 | $16,319 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $11,850 | $63 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $8,468 | $235 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $3,698 | $95 |
| Short return visit (20+ min) | 28 | $2,768 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,682 | $134 |
2022: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 45 | $100,358 | $292 |
| Return visit (30+ min) | 78 | $19,639 | $96 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $17,100 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $9,639 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,950 | $160 |
| Short return visit (20+ min) | 32 | $3,356 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $2,220 | $82 |
| Hemodialysis procedure with physician evaluation | 11 | $647 | $59 |
2021: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $101,737 | $294 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 45 | $30,911 | $245 |
| Return visit (30+ min) | 85 | $15,612 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $8,622 | $58 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $6,069 | $169 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,375 | $163 |
| Short return visit (20+ min) | 45 | $4,769 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $2,963 | $82 |
2020: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 54 | $91,587 | $224 |
| Return visit (30+ min) | 106 | $19,805 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 114 | $17,915 | $57 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $17,777 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $12,127 | $157 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $4,371 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $3,579 | $81 |
| Short return visit (20+ min) | 48 | $3,513 | $56 |
| Hemodialysis procedure with physician evaluation | 12 | $1,544 | $57 |
| Hemodialysis procedure requiring repeated evaluation | 12 | $1,480 | $82 |
2019: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 66 | $107,725 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 207 | $44,349 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 151 | $30,343 | $161 |
| Return visit (30+ min) | 165 | $29,162 | $76 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 47 | $20,865 | $191 |
| Short return visit (20+ min) | 100 | $9,157 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $7,390 | $84 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $6,804 | $145 |
| Hemodialysis procedure requiring repeated evaluation | 32 | $4,337 | $83 |
| Hemodialysis procedure with physician evaluation | 23 | $3,858 | $58 |
| Long return visit (40+ min) | 23 | $2,461 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $2,316 | $110 |
| New patient visit (60+ min) | 11 | $1,530 | $139 |
| New patient visit (45+ min) | 11 | $1,233 | $112 |
2018: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 74 | $119,595 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 222 | $49,118 | $59 |
| Return visit (30+ min) | 179 | $34,053 | $83 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 55 | $28,888 | $191 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 150 | $28,684 | $164 |
| Short return visit (20+ min) | 105 | $11,322 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $8,939 | $84 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $6,623 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $4,301 | $110 |
| New patient visit (60+ min) | 22 | $3,446 | $157 |
| Hemodialysis procedure requiring repeated evaluation | 22 | $3,442 | $80 |
| Hemodialysis procedure with physician evaluation | 26 | $2,945 | $59 |
| Long return visit (40+ min) | 13 | $1,427 | $110 |
2017: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 85 | $136,453 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 219 | $38,414 | $57 |
| Return visit (30+ min) | 178 | $29,478 | $77 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 54 | $24,162 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $18,925 | $160 |
| Short return visit (20+ min) | 139 | $15,990 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $9,038 | $83 |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $4,998 | $147 |
| Hemodialysis procedure requiring repeated evaluation | 27 | $4,219 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $3,254 | $108 |
| Hemodialysis procedure with physician evaluation | 30 | $3,158 | $57 |
2016: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 88 | $137,705 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 245 | $62,707 | $57 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 90 | $43,606 | $191 |
| Return visit (30+ min) | 197 | $27,667 | $75 |
| Short return visit (20+ min) | 184 | $23,410 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 131 | $20,636 | $108 |
| Dialysis services, 1 physician visit per month (20 years or older) | 35 | $12,873 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,130 | $160 |
| Hemodialysis procedure with physician evaluation | 59 | $10,762 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $8,257 | $83 |
| Hemodialysis procedure requiring repeated evaluation | 36 | $5,796 | $83 |
| New patient visit (45+ min) | 22 | $2,902 | $132 |
| New patient visit (60+ min) | 11 | $1,534 | $139 |
2015: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 88 | $126,866 | $228 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 105 | $59,006 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 241 | $52,195 | $58 |
| Return visit (30+ min) | 207 | $28,973 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $24,133 | $84 |
| Short return visit (20+ min) | 173 | $20,772 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 110 | $17,396 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $14,517 | $161 |
| Dialysis services, 1 physician visit per month (20 years or older) | 31 | $13,745 | $149 |
| Hemodialysis procedure with physician evaluation | 51 | $7,532 | $58 |
| Hemodialysis procedure requiring repeated evaluation | 33 | $4,698 | $84 |
| New patient visit (45+ min) | 11 | $1,471 | $134 |
| Long return visit (40+ min) | 13 | $1,188 | $91 |
2014: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 100 | $161,801 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 245 | $62,598 | $58 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 72 | $36,461 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 135 | $30,737 | $84 |
| Return visit (30+ min) | 168 | $29,936 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 136 | $25,274 | $159 |
| Short return visit (20+ min) | 159 | $20,519 | $57 |
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $13,280 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 85 | $13,020 | $106 |
| Hemodialysis procedure with physician evaluation | 37 | $6,717 | $59 |
| Long return visit (40+ min) | 22 | $2,683 | $117 |
| Hemodialysis procedure requiring repeated evaluation | 18 | $2,368 | $85 |
| New patient visit (60+ min) | 11 | $1,580 | $144 |
| New patient visit (45+ min) | 11 | $1,362 | $124 |
2013: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 86 | $110,299 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 345 | $91,371 | $56 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 89 | $38,048 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 205 | $31,281 | $81 |
| Return visit (30+ min) | 187 | $28,290 | $79 |
| Short return visit (20+ min) | 200 | $22,656 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $19,817 | $154 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 146 | $19,805 | $105 |
| Hemodialysis procedure with physician evaluation | 61 | $10,668 | $57 |
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $10,631 | $148 |
| Hemodialysis procedure requiring repeated evaluation | 54 | $7,453 | $82 |
| New patient visit (60+ min) | 14 | $2,094 | $150 |
| New patient visit (45+ min) | 15 | $1,880 | $125 |
| Long return visit (40+ min) | 15 | $1,744 | $116 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $1,144 | $95 |
Medicaid work
$48,243 in 2024
Medicaid paid $48,243 for 256 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 202 | $40,714 |
| Clinic visit/encounter, all-inclusive | 42 | $7,030 |
| Return visit (30+ min) | 12 | $499 |
| 2024 | 256 | 3 | 23 | $48,243 |
| 2023 | 543 | 4 | 30 | $80,759 |
| 2022 | 409 | 4 | 33 | $74,019 |
| 2021 | 655 | 6 | 36 | $99,248 |
| 2020 | 833 | 7 | 48 | $97,733 |
| 2019 | 1,731 | 8 | 51 | $128,157 |
| 2018 | 1,954 | 8 | 59 | $147,751 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 281 | $62,392 |
| Clinic visit/encounter, all-inclusive | 59 | $9,535 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 162 | $6,922 |
| Return visit (30+ min) | 41 | $1,910 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 349 | $68,457 |
| Clinic visit/encounter, all-inclusive | 26 | $4,040 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 22 | $763 |
| Return visit (30+ min) | 12 | $759 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 359 | $69,868 |
| Clinic visit/encounter, all-inclusive | 131 | $20,354 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 49 | $7,242 |
| Return visit (30+ min) | 29 | $1,416 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 22 | $368 |
| Short return visit (20+ min) | 65 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 492 | $68,528 |
| Clinic visit/encounter, all-inclusive | 112 | $17,189 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 39 | $5,125 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 91 | $3,444 |
| Return visit (30+ min) | 75 | $2,402 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $1,045 |
| Short return visit (20+ min) | 12 | $0 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 525 | $67,278 |
| Clinic visit/encounter, all-inclusive | 180 | $27,488 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 671 | $16,255 |
| 1ST HOSP IP/OBS HIGH 75 | 93 | $5,926 |
| Return visit (30+ min) | 157 | $5,059 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 33 | $3,264 |
| Short return visit (20+ min) | 42 | $1,559 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 30 | $1,328 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 560 | $65,394 |
| Clinic visit/encounter, all-inclusive | 224 | $34,030 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 736 | $19,635 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 129 | $15,413 |
| 1ST HOSP IP/OBS HIGH 75 | 93 | $6,080 |
| Return visit (30+ min) | 148 | $4,931 |
| Short return visit (20+ min) | 51 | $1,943 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 13 | $325 |
Drugs they prescribed that Part D paid
$48,492
Pharmacies billed $48,492 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
426 generic and fewer than 11 brand-name prescriptions · $48,492 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prosol | 53 | $9,994 | $189 |
| Sevelamer Carbonate | 13 | $1,922 | $148 |
| Calcium Acetate | 21 | $1,005 | $48 |
| Nifedipine Er | 13 | $538 | $41 |
| Furosemide | 49 | $410 | $8 |
See all 14 drugs
| Prosol | 53 | $9,994 | $189 |
| Sevelamer Carbonate | 13 | $1,922 | $148 |
| Calcium Acetate | 21 | $1,005 | $48 |
| Nifedipine Er | 13 | $538 | $41 |
| Furosemide | 49 | $410 | $8 |
| Allopurinol | 28 | $359 | $13 |
| Calcitriol | 19 | $354 | $19 |
| Hydralazine | 27 | $281 | $10 |
| Metoprolol | 13 | $194 | $15 |
| Lisinopril | 28 | $161 | $6 |
| Atorvastatin | 20 | $161 | $8 |
| Losartan | 28 | $160 | $6 |
| Amlodipine Besylate | 47 | $144 | $3 |
| Prednisone | 14 | $99 | $7 |
Year by year
| 2024 | 529 | 83 | None | None | $48,492 |
| 2023 | 522 | 91 | None | None | $81,949 |
| 2022 | 813 | 100 | None | None | $111,369 |
| 2021 | 1,067 | 127 | None | None | $91,518 |
| 2020 | 1,264 | 156 | None | None | $150,222 |
| 2019 | 1,569 | 184 | None | None | $224,448 |
| 2018 | 2,540 | 199 | None | 19% | $435,960 |
| 2017 | 3,123 | 207 | 1% (15) | 25% | $652,302 |
| 2016 | 4,098 | 259 | 1% (56) | 27% | $900,944 |
| 2015 | 3,765 | 256 | 2% (68) | 27% | $724,011 |
| 2014 | 3,685 | 234 | 2% (62) | 28% | $675,342 |
| 2013 | 3,279 | 216 | 3% (89) | 28% | $469,631 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Cinacalcet | 11 | $19,954 | $1,814 |
| Sevelamer Carbonate | 16 | $5,129 | $321 |
| Calcium Acetate | 17 | $3,292 | $194 |
| Nifedipine Er | 23 | $1,065 | $46 |
| Furosemide | 47 | $925 | $20 |
| Calcitriol | 18 | $907 | $50 |
| Hydralazine | 23 | $743 | $32 |
| Amlodipine Besylate | 42 | $634 | $15 |
| Allopurinol | 20 | $471 | $24 |
| Lisinopril | 18 | $376 | $21 |
| Atorvastatin | 37 | $369 | $10 |
| Losartan | 26 | $280 | $11 |
| Lorazepam | 12 | $244 | $20 |
| Valsartan | 12 | $186 | $15 |
| Prednisone | 11 | $151 | $14 |
2022: 25 drugs
| Velphoro | 19 | $36,593 | $1,926 |
| Sevelamer Carbonate | 48 | $20,686 | $431 |
| Prosol | 57 | $7,778 | $136 |
| Calcium Acetate | 33 | $4,520 | $137 |
| Calcitriol | 29 | $1,675 | $58 |
| Furosemide | 83 | $1,002 | $12 |
| Gabapentin | 20 | $966 | $48 |
| Nifedipine Er | 17 | $779 | $46 |
| Losartan | 57 | $659 | $12 |
| Hydralazine | 24 | $618 | $26 |
| Amlodipine Besylate | 55 | $485 | $9 |
| Isosorbide Mononitrate Er | 13 | $472 | $36 |
| Allopurinol | 21 | $437 | $21 |
| Metoprolol | 12 | $365 | $30 |
| Minoxidil | 18 | $351 | $19 |
| Valsartan | 11 | $330 | $30 |
| Carvedilol | 14 | $303 | $22 |
| Clonidine | 19 | $303 | $16 |
| Lorazepam | 12 | $182 | $15 |
| Atorvastatin | 38 | $173 | $5 |
| Metoprolol | 28 | $166 | $6 |
| Glipizide Er | 11 | $83 | $8 |
| Prednisone | 15 | $68 | $5 |
| Atenolol | 12 | $65 | $5 |
| Hydrochlorothiazide | 11 | $32 | $3 |
2021: 27 drugs
| Sevelamer Carbonate | 81 | $12,879 | $159 |
| Renvela | 12 | $11,312 | $943 |
| Prosol | 52 | $9,028 | $174 |
| Cinacalcet | 17 | $6,641 | $391 |
| Calcium Acetate | 42 | $5,945 | $142 |
| Nifedipine Er | 53 | $2,242 | $42 |
| Calcitriol | 42 | $1,832 | $44 |
| Hydralazine | 53 | $921 | $17 |
| Furosemide | 108 | $824 | $8 |
| Losartan | 58 | $675 | $12 |
| Amlodipine Besylate | 68 | $609 | $9 |
| Allopurinol | 33 | $404 | $12 |
| Minoxidil | 16 | $399 | $25 |
| Gabapentin | 19 | $377 | $20 |
| Metoprolol | 23 | $370 | $16 |
| Lisinopril | 31 | $325 | $10 |
| Clonidine | 19 | $273 | $14 |
| Carvedilol | 19 | $233 | $12 |
| Metoprolol | 30 | $152 | $5 |
| Metformin | 14 | $106 | $8 |
| Atorvastatin | 22 | $104 | $5 |
| Lorazepam | 13 | $94 | $7 |
| Clopidogrel | 16 | $89 | $6 |
| Glipizide Er | 11 | $88 | $8 |
| Prednisone | 16 | $76 | $5 |
| Hydrochlorothiazide | 21 | $61 | $3 |
| Atenolol | 19 | $59 | $3 |
2020: 31 drugs
| Renvela | 30 | $39,463 | $1,315 |
| Sevelamer Carbonate | 60 | $25,169 | $419 |
| Januvia | 16 | $12,718 | $795 |
| Prosol | 52 | $8,133 | $156 |
| Cinacalcet | 13 | $7,128 | $548 |
| Calcium Acetate | 60 | $6,890 | $115 |
| Nifedipine Er | 79 | $3,436 | $43 |
| Calcitriol | 58 | $2,244 | $39 |
| Sodium Polystyrene Sulfonate | 11 | $915 | $83 |
| Hydralazine | 43 | $685 | $16 |
| Losartan | 68 | $667 | $10 |
| Allopurinol | 39 | $654 | $17 |
| Furosemide | 83 | $532 | $6 |
| Atorvastatin | 41 | $500 | $12 |
| Amlodipine Besylate | 77 | $492 | $6 |
| Metoprolol | 19 | $455 | $24 |
| Clonidine | 27 | $426 | $16 |
| Lisinopril | 51 | $327 | $6 |
| Carvedilol | 37 | $287 | $8 |
| Gabapentin | 32 | $247 | $8 |
| Metformin | 12 | $116 | $10 |
| Tamsulosin | 13 | $111 | $9 |
| Metoprolol | 15 | $96 | $6 |
| Hydrochlorothiazide | 17 | $83 | $5 |
| Glipizide Er | 11 | $83 | $8 |
| Atenolol | 20 | $75 | $4 |
| Clopidogrel | 13 | $74 | $6 |
| Famotidine | 11 | $69 | $6 |
| Prednisone | 23 | $68 | $3 |
| Lorazepam | 11 | $67 | $6 |
| Glipizide | 11 | $30 | $3 |
2019: 35 drugs
| Renvela | 66 | $106,765 | $1,618 |
| Sevelamer Carbonate | 65 | $24,823 | $382 |
| Januvia | 26 | $17,481 | $672 |
| Sensipar | 12 | $9,896 | $825 |
| Prosol | 42 | $6,918 | $165 |
| Nifedipine Er | 97 | $4,481 | $46 |
| Calcium Acetate | 39 | $3,590 | $92 |
| Calcitriol | 90 | $2,410 | $27 |
| Allopurinol | 46 | $1,041 | $23 |
| Amlodipine Besylate | 117 | $861 | $7 |
| Atorvastatin | 46 | $786 | $17 |
| Hydralazine | 51 | $739 | $14 |
| Metoprolol | 20 | $707 | $35 |
| Gabapentin | 44 | $697 | $16 |
| Losartan | 84 | $617 | $7 |
| Carvedilol | 41 | $587 | $14 |
| Furosemide | 110 | $556 | $5 |
| Clonidine | 37 | $536 | $14 |
| Bumetanide | 11 | $528 | $48 |
| Lisinopril | 64 | $497 | $8 |
| Tamsulosin | 19 | $446 | $23 |
| Simvastatin | 24 | $370 | $15 |
| Levothyroxine | 16 | $358 | $22 |
| Valsartan | 13 | $358 | $28 |
| Glimepiride | 17 | $216 | $13 |
| Lorazepam | 13 | $213 | $16 |
| Pantoprazole | 12 | $191 | $16 |
| Labetalol | 11 | $152 | $14 |
| Metformin | 13 | $137 | $11 |
| Clopidogrel | 11 | $129 | $12 |
| Benazepril | 12 | $128 | $11 |
| Atenolol | 31 | $116 | $4 |
| Metoprolol | 29 | $104 | $4 |
| Famotidine | 12 | $98 | $8 |
| Hydrochlorothiazide | 17 | $53 | $3 |
2018: 44 drugs
| Renvela | 150 | $255,789 | $1,705 |
| Sevelamer Carbonate | 66 | $51,816 | $785 |
| Sensipar | 18 | $19,198 | $1,067 |
| Januvia | 38 | $16,429 | $432 |
| Prosol | 50 | $7,881 | $158 |
| Nifedipine Er | 146 | $5,520 | $38 |
| Lantus | 17 | $4,520 | $266 |
| Calcium Acetate | 66 | $4,218 | $64 |
| Colchicine | 11 | $3,970 | $361 |
| Calcitriol | 107 | $3,168 | $30 |
| Metoprolol | 46 | $1,599 | $35 |
| Hydralazine | 78 | $1,308 | $17 |
| Tamsulosin | 44 | $1,146 | $26 |
| Atorvastatin | 95 | $985 | $10 |
| Amlodipine Besylate | 150 | $973 | $6 |
| Allopurinol | 64 | $904 | $14 |
| Losartan | 141 | $865 | $6 |
| Metolazone | 11 | $848 | $77 |
| Gabapentin | 93 | $795 | $9 |
| Clonidine | 69 | $748 | $11 |
| Furosemide | 105 | $565 | $5 |
| Levothyroxine | 25 | $555 | $22 |
| Carvedilol | 92 | $537 | $6 |
| Valsartan | 14 | $429 | $31 |
| Omeprazole | 48 | $397 | $8 |
| Isosorbide Mononitrate Er | 18 | $382 | $21 |
| Potassium Chloride | 14 | $340 | $24 |
| Simvastatin | 37 | $333 | $9 |
| Glimepiride | 27 | $321 | $12 |
| Lisinopril | 49 | $286 | $6 |
| Pantoprazole | 25 | $220 | $9 |
| Metoprolol | 54 | $214 | $4 |
| Enalapril Maleate | 11 | $211 | $19 |
| Amitriptyline | 15 | $179 | $12 |
| Atenolol | 55 | $170 | $3 |
| Metformin | 28 | $161 | $6 |
| Clopidogrel | 30 | $149 | $5 |
| Minoxidil | 11 | $143 | $13 |
| Benazepril | 11 | $128 | $12 |
| Hydroxyzine | 11 | $127 | $12 |
| Prednisone | 20 | $124 | $6 |
| Famotidine | 18 | $101 | $6 |
| Sertraline | 18 | $68 | $4 |
| Glipizide | 14 | $19 | $1 |
2017: 55 drugs
| Renvela | 212 | $319,258 | $1,506 |
| Sensipar | 97 | $175,029 | $1,804 |
| Lantus | 53 | $16,638 | $314 |
| Intralipid | 47 | $16,353 | $348 |
| Januvia | 32 | $12,783 | $399 |
| Lantus Solostar | 20 | $8,938 | $447 |
| Byetta | 12 | $8,121 | $677 |
| Calcium Acetate | 60 | $7,370 | $123 |
| Calcitriol | 173 | $6,143 | $36 |
| Nifedipine Er | 166 | $5,348 | $32 |
| Novolog | 12 | $4,115 | $343 |
| Ranexa | 11 | $3,786 | $344 |
| Prosol | 11 | $3,236 | $294 |
| Bumetanide | 15 | $1,682 | $112 |
| Metoprolol | 71 | $1,397 | $20 |
| Tamsulosin | 50 | $1,146 | $23 |
| Amlodipine Besylate | 251 | $1,104 | $4 |
| Hydralazine | 93 | $1,065 | $11 |
| Insulin | 23 | $1,006 | $44 |
| Metolazone | 17 | $939 | $55 |
| Allopurinol | 67 | $890 | $13 |
| Levothyroxine | 49 | $743 | $15 |
| Atorvastatin | 91 | $701 | $8 |
| Clonidine | 73 | $691 | $9 |
| Furosemide | 157 | $684 | $4 |
| Labetalol | 18 | $657 | $36 |
| Potassium Chloride | 24 | $643 | $27 |
| Losartan | 115 | $621 | $5 |
| Phenytoin Sodium Extended | 13 | $465 | $36 |
| Carvedilol | 103 | $449 | $4 |
| Lisinopril | 79 | $394 | $5 |
| Simvastatin | 60 | $389 | $6 |
| Omeprazole | 67 | $388 | $6 |
| Isosorbide Mononitrate Er | 19 | $342 | $18 |
| Glimepiride | 19 | $337 | $18 |
| Gabapentin | 66 | $296 | $4 |
| Amitriptyline | 25 | $276 | $11 |
| Metoprolol | 71 | $269 | $4 |
| Minoxidil | 14 | $206 | $15 |
| Pioglitazone | 15 | $202 | $13 |
| Benazepril | 11 | $201 | $18 |
| Spironolactone | 14 | $188 | $13 |
| Metformin | 22 | $177 | $8 |
| Pantoprazole | 21 | $166 | $8 |
| Hydroxyzine | 11 | $133 | $12 |
| Enalapril Maleate | 16 | $120 | $7 |
| Prednisone | 15 | $120 | $8 |
| Clopidogrel | 26 | $96 | $4 |
| Atenolol | 42 | $95 | $2 |
| Metoclopramide | 16 | $90 | $6 |
| Famotidine | 22 | $75 | $3 |
| Alendronate | 13 | $72 | $6 |
| Nortriptyline | 12 | $52 | $4 |
| Sertraline | 15 | $40 | $3 |
| Glipizide | 17 | $40 | $2 |
2016: 58 drugs
| Renvela | 314 | $520,960 | $1,659 |
| Sensipar | 138 | $176,278 | $1,277 |
| Intralipid | 61 | $21,329 | $350 |
| Lantus | 48 | $18,460 | $385 |
| Renagel | 15 | $16,166 | $1,078 |
| Calcium Acetate | 114 | $13,747 | $121 |
| Januvia | 28 | $10,409 | $372 |
| Novolog | 21 | $8,207 | $391 |
| Byetta | 12 | $7,225 | $602 |
| Calcitriol | 253 | $7,130 | $28 |
| Prosol | 36 | $5,916 | $164 |
| Lantus Solostar | 16 | $5,874 | $367 |
| Nifedipine Er | 147 | $5,800 | $39 |
| Uloric | 16 | $4,523 | $283 |
| Metoprolol | 79 | $1,792 | $23 |
| Metolazone | 23 | $1,764 | $77 |
| Tamsulosin | 51 | $1,686 | $33 |
| Hydralazine | 134 | $1,685 | $13 |
| Valsartan | 11 | $1,345 | $122 |
| Nifedical Xl | 47 | $1,209 | $26 |
| Allopurinol | 90 | $1,184 | $13 |
| Amlodipine Besylate | 304 | $1,149 | $4 |
| Losartan | 172 | $1,140 | $7 |
| Atorvastatin | 135 | $1,065 | $8 |
| Bumetanide | 14 | $967 | $69 |
| Potassium Chloride | 18 | $931 | $52 |
| Furosemide | 187 | $876 | $5 |
| Insulin | 19 | $754 | $40 |
| Clonidine | 62 | $606 | $10 |
| Omeprazole | 96 | $596 | $6 |
| Levothyroxine | 40 | $575 | $14 |
| Carvedilol | 103 | $528 | $5 |
| Lisinopril | 99 | $510 | $5 |
| Doxazosin Mesylate | 19 | $496 | $26 |
| Gabapentin | 84 | $482 | $6 |
| Simvastatin | 84 | $474 | $6 |
| Afeditab Cr | 12 | $435 | $36 |
| Labetalol | 16 | $430 | $27 |
| Atenolol | 90 | $378 | $4 |
| Isosorbide Mononitrate Er | 26 | $352 | $14 |
| Hydrocodone-Acetaminophen | 22 | $342 | $16 |
| Metoprolol | 110 | $335 | $3 |
| Pioglitazone | 23 | $273 | $12 |
| Enalapril Maleate | 23 | $264 | $11 |
| Glimepiride | 11 | $259 | $24 |
| Loperamide | 12 | $222 | $18 |
| Metformin | 27 | $217 | $8 |
| Pantoprazole | 30 | $201 | $7 |
| Amitriptyline | 17 | $181 | $11 |
| Famotidine | 25 | $150 | $6 |
| Tramadol | 34 | $130 | $4 |
| Clopidogrel | 26 | $124 | $5 |
| Glipizide | 44 | $113 | $3 |
| Hydroxyzine | 11 | $106 | $10 |
| Sertraline | 27 | $87 | $3 |
| Spironolactone | 14 | $79 | $6 |
| Warfarin | 11 | $76 | $7 |
| Hydrochlorothiazide | 13 | $24 | $2 |
2015: 60 drugs
| Renvela | 279 | $416,106 | $1,491 |
| Sensipar | 97 | $78,174 | $806 |
| Doxercalciferol | 13 | $36,107 | $2,777 |
| Renagel | 23 | $34,547 | $1,502 |
| Lantus | 47 | $20,510 | $436 |
| Januvia | 20 | $10,402 | $520 |
| Calcium Acetate | 85 | $10,342 | $122 |
| Novolog | 21 | $8,492 | $404 |
| Nexium | 23 | $7,100 | $309 |
| Prosol | 38 | $6,967 | $183 |
| Byetta | 11 | $6,427 | $584 |
| Calcitriol | 256 | $6,121 | $24 |
| Uloric | 20 | $5,190 | $260 |
| Nifedipine Er | 144 | $4,814 | $33 |
| Intralipid | 13 | $4,618 | $355 |
| Valsartan | 18 | $2,304 | $128 |
| Hydralazine | 116 | $2,051 | $18 |
| Metoprolol | 71 | $1,917 | $27 |
| Bumetanide | 19 | $1,631 | $86 |
| Novolin R | 13 | $1,588 | $122 |
| Allopurinol | 102 | $1,291 | $13 |
| Tamsulosin | 31 | $1,224 | $39 |
| Amlodipine Besylate | 243 | $1,059 | $4 |
| Afeditab Cr | 33 | $955 | $29 |
| Metolazone | 20 | $804 | $40 |
| Furosemide | 198 | $796 | $4 |
| Losartan | 141 | $765 | $5 |
| Atorvastatin | 76 | $759 | $10 |
| Omeprazole | 99 | $676 | $7 |
| Metoprolol | 125 | $583 | $5 |
| Enalapril Maleate | 28 | $573 | $20 |
| Gabapentin | 65 | $559 | $9 |
| Lisinopril | 99 | $531 | $5 |
| Insulin | 21 | $527 | $25 |
| Labetalol | 11 | $523 | $48 |
| Potassium Chloride | 22 | $519 | $24 |
| Carvedilol | 87 | $489 | $6 |
| Simvastatin | 95 | $476 | $5 |
| Levothyroxine | 23 | $444 | $19 |
| Hydrocodone-Acetaminophen | 24 | $439 | $18 |
| Pioglitazone | 23 | $387 | $17 |
| Atenolol | 67 | $377 | $6 |
| Metformin | 37 | $348 | $9 |
| Isosorbide Mononitrate Er | 35 | $302 | $9 |
| Glimepiride | 17 | $286 | $17 |
| Tramadol | 43 | $274 | $6 |
| Famotidine | 28 | $266 | $10 |
| Warfarin | 35 | $263 | $8 |
| Clonidine | 27 | $247 | $9 |
| Sertraline | 34 | $224 | $7 |
| Clopidogrel | 29 | $191 | $7 |
| Spironolactone | 28 | $182 | $7 |
| Hydroxyzine | 18 | $177 | $10 |
| Glipizide | 53 | $159 | $3 |
| Amitriptyline | 11 | $151 | $14 |
| Pantoprazole | 21 | $135 | $6 |
| Diltiazem | 11 | $116 | $11 |
| Zolpidem | 13 | $111 | $9 |
| Azithromycin | 15 | $87 | $6 |
| Hydrochlorothiazide | 11 | $48 | $4 |
2014: 67 drugs
| Renvela | 280 | $355,112 | $1,268 |
| Sensipar | 117 | $74,168 | $634 |
| Lantus | 42 | $16,361 | $390 |
| Intralipid | 42 | $13,667 | $325 |
| Prosol | 62 | $9,891 | $160 |
| Calcitriol | 261 | $9,063 | $35 |
| Calcium Acetate | 63 | $8,703 | $138 |
| Nifedipine Er | 125 | $6,283 | $50 |
| Januvia | 16 | $5,940 | $371 |
| Nexium | 22 | $5,803 | $264 |
| Diovan | 24 | $5,285 | $220 |
| Novolog | 16 | $4,861 | $304 |
| Colcrys | 13 | $4,094 | $315 |
| Uloric | 14 | $3,303 | $236 |
| Clinisol | 17 | $2,955 | $174 |
| Kionex | 12 | $1,620 | $135 |
| Metoprolol | 40 | $1,519 | $38 |
| Bumetanide | 14 | $1,399 | $100 |
| Sodium Polystyrene Sulfonate | 11 | $1,224 | $111 |
| Amlodipine Besylate | 172 | $1,104 | $6 |
| Hydralazine | 52 | $1,067 | $21 |
| Losartan | 120 | $1,058 | $9 |
| Ventolin Hfa | 22 | $1,034 | $47 |
| Furosemide | 175 | $989 | $6 |
| Potassium Chloride | 30 | $872 | $29 |
| Omeprazole | 121 | $821 | $7 |
| Atorvastatin | 49 | $782 | $16 |
| Pioglitazone | 27 | $766 | $28 |
| Simvastatin | 100 | $748 | $7 |
| Lactulose | 15 | $698 | $47 |
| Labetalol | 11 | $680 | $62 |
| Atenolol | 118 | $618 | $5 |
| Metolazone | 25 | $617 | $25 |
| Carvedilol | 70 | $564 | $8 |
| Levothyroxine | 43 | $532 | $12 |
| Hydrocodone-Acetaminophen | 23 | $494 | $21 |
| Allopurinol | 72 | $491 | $7 |
| Cartia Xt | 14 | $491 | $35 |
| Lisinopril | 95 | $470 | $5 |
| Metformin | 63 | $468 | $7 |
| Isosorbide Mononitrate Er | 38 | $414 | $11 |
| Metoprolol | 88 | $393 | $4 |
| Gabapentin | 52 | $371 | $7 |
| Enalapril Maleate | 34 | $364 | $11 |
| Clonidine | 39 | $356 | $9 |
| Tamsulosin | 20 | $353 | $18 |
| Diphenoxylate-Atropine | 15 | $318 | $21 |
| Sure Comfort | 11 | $310 | $28 |
| Minoxidil | 12 | $308 | $26 |
| Pantoprazole | 24 | $299 | $12 |
| Glimepiride | 21 | $288 | $14 |
| Glipizide | 45 | $288 | $6 |
| Hydroxyzine | 16 | $251 | $16 |
| Famotidine | 39 | $250 | $6 |
| Zolpidem | 27 | $237 | $9 |
| Tramadol | 38 | $219 | $6 |
| Spironolactone | 28 | $193 | $7 |
| Hydrochlorothiazide | 40 | $178 | $4 |
| Paroxetine | 20 | $173 | $9 |
| Sertraline | 16 | $146 | $9 |
| Warfarin | 21 | $138 | $7 |
| Lorazepam | 22 | $131 | $6 |
| Clopidogrel | 17 | $127 | $7 |
| Diltiazem | 12 | $102 | $8 |
| Lovastatin | 11 | $97 | $9 |
| Trazodone | 13 | $95 | $7 |
| Alprazolam | 11 | $93 | $8 |
2013: 61 drugs
| Renvela | 253 | $248,748 | $983 |
| Sensipar | 111 | $55,049 | $496 |
| Renagel | 12 | $19,672 | $1,639 |
| Clinisol | 50 | $15,491 | $310 |
| Calcitriol | 315 | $14,410 | $46 |
| Diovan | 48 | $9,800 | $204 |
| Lantus | 34 | $7,823 | $230 |
| Intralipid | 20 | $5,844 | $292 |
| Nifedipine Er | 86 | $5,353 | $62 |
| Prosol | 33 | $4,753 | $144 |
| Nexium | 20 | $4,330 | $217 |
| Colcrys | 16 | $4,312 | $270 |
| Qvar | 13 | $4,185 | $322 |
| Calcium Acetate | 29 | $4,168 | $144 |
| Pioglitazone | 27 | $3,718 | $138 |
| Januvia | 11 | $2,842 | $258 |
| Serevent Diskus | 13 | $2,531 | $195 |
| Metoprolol | 55 | $2,167 | $39 |
| Losartan | 113 | $1,620 | $14 |
| Omeprazole | 99 | $1,577 | $16 |
| Clopidogrel | 24 | $1,401 | $58 |
| Amlodipine Besylate | 161 | $1,311 | $8 |
| Furosemide | 178 | $933 | $5 |
| Potassium Chloride | 34 | $867 | $25 |
| Simvastatin | 85 | $845 | $10 |
| Atorvastatin | 33 | $701 | $21 |
| Atenolol | 131 | $685 | $5 |
| Hydrocodone-Acetaminophen | 36 | $631 | $18 |
| Metformin | 64 | $569 | $9 |
| Minoxidil | 13 | $494 | $38 |
| Lisinopril | 75 | $493 | $7 |
| Metolazone | 24 | $472 | $20 |
| Levothyroxine | 46 | $456 | $10 |
| Clonidine | 35 | $449 | $13 |
| Hydralazine | 25 | $436 | $17 |
| Carvedilol | 44 | $421 | $10 |
| Tramadol | 52 | $399 | $8 |
| Amlodipine Besylate-Benazepril | 12 | $375 | $31 |
| Paroxetine | 26 | $344 | $13 |
| Hydrochlorothiazide | 48 | $335 | $7 |
| Pantoprazole | 20 | $322 | $16 |
| Cartia Xt | 11 | $302 | $27 |
| Tamsulosin | 18 | $297 | $17 |
| Metoprolol | 64 | $297 | $5 |
| Glipizide | 28 | $292 | $10 |
| Lovastatin | 23 | $287 | $12 |
| Enalapril Maleate | 45 | $276 | $6 |
| Gabapentin | 19 | $229 | $12 |
| Hydroxyzine | 13 | $223 | $17 |
| Allopurinol | 32 | $218 | $7 |
| Sertraline | 20 | $214 | $11 |
| Diphenoxylate-Atropine | 17 | $210 | $12 |
| Isosorbide Mononitrate Er | 20 | $198 | $10 |
| Azithromycin | 15 | $144 | $10 |
| Lorazepam | 21 | $144 | $7 |
| Amiodarone | 15 | $136 | $9 |
| Spironolactone | 11 | $114 | $10 |
| Promethazine | 13 | $110 | $8 |
| Prednisone | 19 | $106 | $6 |
| Warfarin | 12 | $102 | $9 |
| Zolpidem | 14 | $68 | $5 |
Money from drug and device companies
$12 in 2022
A payment is not proof that care is biased.
| Vifor Pharma | None | $12 | 1 payment
|
See the published payment
| Vifor Pharma | Education · 2022-05-17 | None | $12 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1275637506
- Licence
- CA A42706California A42706: Current · expires 2028-04-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA GR0100620
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 3351 M Street, Ste 125, Merced, CA, 95348
- NPI first listed
- 2006-09-08
- NPI last updated
- 2014-10-08
This is when the NPI record was last certified, not a medical board exam.